# pathway_0070

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **B** — Secondary metabolite biosynthesis

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MWSLIPLTAIVLVLVAILHRLFFHPLSHVPGPFLARFSSLYLHSICYLGIEATVLRQLHIKYKTKVLRVAPNSVSISDSEAVGEIYVRGGGFPKDDRYKNFNLGPIVSIFSSLDREYRDVRAKAVAPLFSPAQLRAESGPQGVIGGCIAEFVDQLRKSKEAGIGADLMDMCARLSIDVVTGYLLGQKYGGLQENAHLPPQERQSHKLSANPFIFSIVAFSRFSLLPHRIFQFLYSTSQRLSTNDEVTESFLKLDRFTNNVLEGTTAGEKVSEKPNGGYYHERLISQAGISRMEAAAQSQAVLFAGADSTAVMLATILFHLVQNGAARSRLLCEVRSDKPQDMRFLRAVVKEGLRLGMANPTRMTRVVPKSGPGLRVGDVLLSPGTIVGCAAYNLHHDPEVFPDPFTFRPERWLDDGTDRGLRRPGMEKSMIPFGVGSRACIGKNLAQQQLHDTVVAVIDSEVLEGARTCQERIEIIEWFNADIKGHHLDIKWS

[Multiple Choices]
A. Alkaloid biosynthesis
B. Secondary metabolite biosynthesis
C. Antifungal biosynthesis. .
D. Purine metabolism
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches a UniProt record annotating the protein’s pathway as secondary metabolite biosynthesis and terpenoid biosynthesis. The annotation cites experimental evidence (ECO:0000269) and a 2024 publication, though the cited study was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The N-terminal hydrophobic segment is consistent with a membrane-associated enzyme, and the sequence is compatible with a cytochrome P450. That does not establish which particular biosynthetic pathway it serves.


**Missing item-specific fact**

> The protein’s specific role in terpenoid/secondary-metabolite biosynthesis, established by its annotation or experimental association with the relevant biosynthetic cluster.


**Reason**

> The sequence alone does not meaningfully distinguish a secondary-metabolite pathway from other possible P450 functions. The supported choice depends on protein-specific functional evidence absent from the question.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The choices are broad and may overlap conceptually, but the supplied evidence supports secondary metabolite biosynthesis; it does not establish that the product is an antifungal.


### Important caveats

- The reviewer-only record matches the supplied sequence, but that annotation was not available to the evaluated model.
- The pathway annotation cites experimental evidence, but the underlying primary paper was not independently assessed.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The N-terminal hydrophobic segment is consistent with a membrane-associated enzyme, and the sequence is compatible with a cytochrome P450. That does not establish which particular biosynthetic pathway it serves.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein’s specific role in terpenoid/secondary-metabolite biosynthesis, established by its annotation or experimental association with the relevant biosynthetic cluster.",
    "reason": "The sequence alone does not meaningfully distinguish a secondary-metabolite pathway from other possible P450 functions. The supported choice depends on protein-specific functional evidence absent from the question."
  },
  "case_id": "pathway_0070",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt record annotating the protein’s pathway as secondary metabolite biosynthesis and terpenoid biosynthesis. The annotation cites experimental evidence (ECO:0000269) and a 2024 publication, though the cited study was not independently reviewed here."
  },
  "important_caveats": [
    "The reviewer-only record matches the supplied sequence, but that annotation was not available to the evaluated model.",
    "The pathway annotation cites experimental evidence, but the underlying primary paper was not independently assessed."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices are broad and may overlap conceptually, but the supplied evidence supports secondary metabolite biosynthesis; it does not establish that the product is an antifungal."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0070",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches a UniProt record annotating the protein’s pathway as secondary metabolite biosynthesis and terpenoid biosynthesis. The annotation cites experimental evidence (ECO:0000269) and a 2024 publication, though the cited study was not independently reviewed here.",
    "evidence_ids": ["C5", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The N-terminal hydrophobic segment is consistent with a membrane-associated enzyme, and the sequence is compatible with a cytochrome P450. That does not establish which particular biosynthetic pathway it serves.",
    "missing_item_specific_fact": "The protein’s specific role in terpenoid/secondary-metabolite biosynthesis, established by its annotation or experimental association with the relevant biosynthetic cluster.",
    "reason": "The sequence alone does not meaningfully distinguish a secondary-metabolite pathway from other possible P450 functions. The supported choice depends on protein-specific functional evidence absent from the question."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices are broad and may overlap conceptually, but the supplied evidence supports secondary metabolite biosynthesis; it does not establish that the product is an antifungal."
  },
  "important_caveats": [
    "The reviewer-only record matches the supplied sequence, but that annotation was not available to the evaluated model.",
    "The pathway annotation cites experimental evidence, but the underlying primary paper was not independently assessed."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P9WEG5 (Cytochrome P450 monooxygenase mfmF from Annulohypoxylon moriforme) carries the explicit PATHWAY comment 'Secondary metabolite biosynthesis; terpenoid biosynthesis' backed by experimental evidence (ECO:0000269, PubMed:38404388). The expected answer 'Secondary metabolite biosynthesis' matches the first clause of this annotation exactly. The protein is involved in the biosynthesis of 11'-O-desmethylfendlerol, a polyketide-terpenoid hybrid secondary metabolite, which is correctly classified under secondary metabolite biosynthesis rather than alkaloid biosynthesis (A), a non-standard 'antifungal biosynthesis' category (C), or purine metabolism (D).

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A model could recognize the FxxGxxxCxG heme-binding motif (visible around 'FGVGSRACIGKNL') as diagnostic of a cytochrome P450 monooxygenase, note the fungal context, and eliminate 'Purine metabolism' (D) and the non-standard 'Antifungal biosynthesis' (C) as implausible. However, distinguishing 'Alkaloid biosynthesis' (A) from 'Secondary metabolite biosynthesis' (B) based on sequence alone is not feasible: fungal P450s participate in alkaloid, terpenoid, polyketide, and other secondary metabolite pathways with no sequence-level signature that separates them. The correct assignment requires knowing that mfmF acts on a polyketide-terpenoid hybrid (11'-O-desmethylfendlerol), not an alkaloid.


**Missing item-specific fact**

> The specific substrate and biosynthetic context of mfmF (11'-O-desmethylfendlerol, a polyketide-terpenoid hybrid in a fungal BGC), which determines that the pathway is terpenoid/polyketide secondary metabolism rather than alkaloid biosynthesis. This information resides in the UniProt annotation and the 2024 Yan & Matsuda paper, neither of which is derivable from the 493-aa sequence alone.


**Reason**

> While general P450 recognition and fungal secondary-metabolism context provide partial narrowing (eliminating D and arguably C), the critical A-vs-B distinction depends on the item-specific fact that the product is a terpenoid-polyketide hybrid rather than an alkaloid. This is a database/experimental annotation fact, not a sequence-derivable property.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options are sufficiently distinct. 'Alkaloid biosynthesis' (A) is a specific sub-category of secondary metabolism that does not apply to a polyketide-terpenoid hybrid. 'Antifungal biosynthesis' (C) is not a recognized pathway term and the trailing '. .' formatting signals a low-quality distractor. 'Purine metabolism' (D) is clearly unrelated to a fungal P450 in a biosynthetic gene cluster. Only B matches the UniProt pathway annotation. No two options are simultaneously defensible given the actual biology.


### Important caveats

- The UniProt pathway annotation 'Secondary metabolite biosynthesis; terpenoid biosynthesis' carries experimental evidence (ECO:0000269) from a 2024 journal article, lending strong support to the key.
- The answer B captures only the broader category; the full annotation specifies 'terpenoid biosynthesis' as the sub-pathway, but no option offers this finer granularity.
- The option C text 'Antifungal biosynthesis. .' contains anomalous punctuation, suggesting a formatting artifact in the benchmark construction.
- The reviewer-only evidence confirms the sequence matches P9WEG5 exactly (SHA-256 identical) in both the current and historical (entry v3, Jan 2026) UniProt records, so the annotation applies to the benchmark sequence.
- The author's source snapshot date is unknown; the entry was first public on 2025-04-09 and the pathway annotation was present by entry version 3 (2026-01-28), so the key was available in any snapshot from that period onward.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A model could recognize the FxxGxxxCxG heme-binding motif (visible around 'FGVGSRACIGKNL') as diagnostic of a cytochrome P450 monooxygenase, note the fungal context, and eliminate 'Purine metabolism' (D) and the non-standard 'Antifungal biosynthesis' (C) as implausible. However, distinguishing 'Alkaloid biosynthesis' (A) from 'Secondary metabolite biosynthesis' (B) based on sequence alone is not feasible: fungal P450s participate in alkaloid, terpenoid, polyketide, and other secondary metabolite pathways with no sequence-level signature that separates them. The correct assignment requires knowing that mfmF acts on a polyketide-terpenoid hybrid (11'-O-desmethylfendlerol), not an alkaloid.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific substrate and biosynthetic context of mfmF (11'-O-desmethylfendlerol, a polyketide-terpenoid hybrid in a fungal BGC), which determines that the pathway is terpenoid/polyketide secondary metabolism rather than alkaloid biosynthesis. This information resides in the UniProt annotation and the 2024 Yan & Matsuda paper, neither of which is derivable from the 493-aa sequence alone.",
    "reason": "While general P450 recognition and fungal secondary-metabolism context provide partial narrowing (eliminating D and arguably C), the critical A-vs-B distinction depends on the item-specific fact that the product is a terpenoid-polyketide hybrid rather than an alkaloid. This is a database/experimental annotation fact, not a sequence-derivable property."
  },
  "case_id": "pathway_0070",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P9WEG5 (Cytochrome P450 monooxygenase mfmF from Annulohypoxylon moriforme) carries the explicit PATHWAY comment 'Secondary metabolite biosynthesis; terpenoid biosynthesis' backed by experimental evidence (ECO:0000269, PubMed:38404388). The expected answer 'Secondary metabolite biosynthesis' matches the first clause of this annotation exactly. The protein is involved in the biosynthesis of 11'-O-desmethylfendlerol, a polyketide-terpenoid hybrid secondary metabolite, which is correctly classified under secondary metabolite biosynthesis rather than alkaloid biosynthesis (A), a non-standard 'antifungal biosynthesis' category (C), or purine metabolism (D)."
  },
  "important_caveats": [
    "The UniProt pathway annotation 'Secondary metabolite biosynthesis; terpenoid biosynthesis' carries experimental evidence (ECO:0000269) from a 2024 journal article, lending strong support to the key.",
    "The answer B captures only the broader category; the full annotation specifies 'terpenoid biosynthesis' as the sub-pathway, but no option offers this finer granularity.",
    "The option C text 'Antifungal biosynthesis. .' contains anomalous punctuation, suggesting a formatting artifact in the benchmark construction.",
    "The reviewer-only evidence confirms the sequence matches P9WEG5 exactly (SHA-256 identical) in both the current and historical (entry v3, Jan 2026) UniProt records, so the annotation applies to the benchmark sequence.",
    "The author's source snapshot date is unknown; the entry was first public on 2025-04-09 and the pathway annotation was present by entry version 3 (2026-01-28), so the key was available in any snapshot from that period onward."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options are sufficiently distinct. 'Alkaloid biosynthesis' (A) is a specific sub-category of secondary metabolism that does not apply to a polyketide-terpenoid hybrid. 'Antifungal biosynthesis' (C) is not a recognized pathway term and the trailing '. .' formatting signals a low-quality distractor. 'Purine metabolism' (D) is clearly unrelated to a fungal P450 in a biosynthetic gene cluster. Only B matches the UniProt pathway annotation. No two options are simultaneously defensible given the actual biology."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0070",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P9WEG5 (Cytochrome P450 monooxygenase mfmF from Annulohypoxylon moriforme) carries the explicit PATHWAY comment 'Secondary metabolite biosynthesis; terpenoid biosynthesis' backed by experimental evidence (ECO:0000269, PubMed:38404388). The expected answer 'Secondary metabolite biosynthesis' matches the first clause of this annotation exactly. The protein is involved in the biosynthesis of 11'-O-desmethylfendlerol, a polyketide-terpenoid hybrid secondary metabolite, which is correctly classified under secondary metabolite biosynthesis rather than alkaloid biosynthesis (A), a non-standard 'antifungal biosynthesis' category (C), or purine metabolism (D).",
    "evidence_ids": ["C5", "H3", "C4", "C6", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A model could recognize the FxxGxxxCxG heme-binding motif (visible around 'FGVGSRACIGKNL') as diagnostic of a cytochrome P450 monooxygenase, note the fungal context, and eliminate 'Purine metabolism' (D) and the non-standard 'Antifungal biosynthesis' (C) as implausible. However, distinguishing 'Alkaloid biosynthesis' (A) from 'Secondary metabolite biosynthesis' (B) based on sequence alone is not feasible: fungal P450s participate in alkaloid, terpenoid, polyketide, and other secondary metabolite pathways with no sequence-level signature that separates them. The correct assignment requires knowing that mfmF acts on a polyketide-terpenoid hybrid (11'-O-desmethylfendlerol), not an alkaloid.",
    "missing_item_specific_fact": "The specific substrate and biosynthetic context of mfmF (11'-O-desmethylfendlerol, a polyketide-terpenoid hybrid in a fungal BGC), which determines that the pathway is terpenoid/polyketide secondary metabolism rather than alkaloid biosynthesis. This information resides in the UniProt annotation and the 2024 Yan & Matsuda paper, neither of which is derivable from the 493-aa sequence alone.",
    "reason": "While general P450 recognition and fungal secondary-metabolism context provide partial narrowing (eliminating D and arguably C), the critical A-vs-B distinction depends on the item-specific fact that the product is a terpenoid-polyketide hybrid rather than an alkaloid. This is a database/experimental annotation fact, not a sequence-derivable property."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options are sufficiently distinct. 'Alkaloid biosynthesis' (A) is a specific sub-category of secondary metabolism that does not apply to a polyketide-terpenoid hybrid. 'Antifungal biosynthesis' (C) is not a recognized pathway term and the trailing '. .' formatting signals a low-quality distractor. 'Purine metabolism' (D) is clearly unrelated to a fungal P450 in a biosynthetic gene cluster. Only B matches the UniProt pathway annotation. No two options are simultaneously defensible given the actual biology."
  },
  "important_caveats": [
    "The UniProt pathway annotation 'Secondary metabolite biosynthesis; terpenoid biosynthesis' carries experimental evidence (ECO:0000269) from a 2024 journal article, lending strong support to the key.",
    "The answer B captures only the broader category; the full annotation specifies 'terpenoid biosynthesis' as the sub-pathway, but no option offers this finer granularity.",
    "The option C text 'Antifungal biosynthesis. .' contains anomalous punctuation, suggesting a formatting artifact in the benchmark construction.",
    "The reviewer-only evidence confirms the sequence matches P9WEG5 exactly (SHA-256 identical) in both the current and historical (entry v3, Jan 2026) UniProt records, so the annotation applies to the benchmark sequence.",
    "The author's source snapshot date is unknown; the entry was first public on 2025-04-09 and the pathway annotation was present by entry version 3 (2026-01-28), so the key was available in any snapshot from that period onward."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `P9WEG5` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 3. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG5.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:30:16.026791+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"38404388","source":"PubMed"}],"value":"11'-O-desmethylfendlerol biosynthesis cluster protein F"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"38404388","source":"PubMed"}],"value":"1.-.-.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"38404388","source":"PubMed"}],"value":"Cytochrome P450 monooxygenase mfmF"}}}
```

Source SHA-256: `dc436df1e2d7691051ca6db34af02a9dec343983045b05a1d392790fcfc89365`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG5.json)  
**Locator:** `/comments/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:30:16.026791+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"38404388","source":"PubMed"}],"value":"Secondary metabolite biosynthesis; terpenoid biosynthesis"}]}
```

Source SHA-256: `dc436df1e2d7691051ca6db34af02a9dec343983045b05a1d392790fcfc89365`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P9WEG5.json)  
**Locator:** `/references/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:30:16.026791+00:00.  

```json
{"citation":{"authors":["Yan D.","Matsuda Y."],"citationCrossReferences":[{"database":"PubMed","id":"38404388"},{"database":"DOI","id":"10.1039/d3sc06001b"}],"citationType":"journal article","firstPage":"3011","id":"38404388","journal":"Chem. Sci.","lastPage":"3017","publicationDate":"2024","title":"Global genome mining-driven discovery of an unusual biosynthetic logic for fungal polyketide-terpenoid hybrids.","volume":"15"},"referenceComments":[{"type":"STRAIN","value":"CBS 123579"}],"referenceNumber":2,"referencePositions":["FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `dc436df1e2d7691051ca6db34af02a9dec343983045b05a1d392790fcfc89365`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG5?format=txt&versions=3)  
**Locator:** `lines 28-35`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 3 / 1.  
**Retrieved:** 2026-11-02T04:30:25.029219+00:00.  

```text
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RC   STRAIN=CBS 123579;
RX   PubMed=38404388; DOI=10.1039/d3sc06001b;
RA   Yan D., Matsuda Y.;
RT   "Global genome mining-driven discovery of an unusual biosynthetic logic for
RT   fungal polyketide-terpenoid hybrids.";
RL   Chem. Sci. 15:3011-3017(2024).
```

Source SHA-256: `af7833e0b12ec6f8aaae74c43fcace02a7efebe1a9b79c53957e96e46119ec32`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P9WEG5?format=txt&versions=3)  
**Locator:** `lines 58-59`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 3 / 1.  
**Retrieved:** 2026-11-02T04:30:25.029219+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.
CC       {ECO:0000269|PubMed:38404388}.
```

Source SHA-256: `af7833e0b12ec6f8aaae74c43fcace02a7efebe1a9b79c53957e96e46119ec32`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 70. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
